185 related articles for article (PubMed ID: 31552168)
41. Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?
Jaber M; Ewelt C; Wölfer J; Brokinkel B; Thomas C; Hasselblatt M; Grauer O; Stummer W
Neurosurgery; 2019 Jun; 84(6):1214-1224. PubMed ID: 30107580
[TBL] [Abstract][Full Text] [Related]
42. 5-Aminolevulinic Acid and (18)F-FET-PET as Metabolic Imaging Tools for Surgery of a Recurrent Skull Base Meningioma.
Cornelius JF; Slotty PJ; Stoffels G; Galldiks N; Langen KJ; Steiger HJ
J Neurol Surg B Skull Base; 2013 Aug; 74(4):211-6. PubMed ID: 24436914
[TBL] [Abstract][Full Text] [Related]
43. 5-aminolevulinic acid-guided surgery for focal pediatric brainstem gliomas: A preliminary study.
Labuschagne J
Surg Neurol Int; 2020; 11():334. PubMed ID: 33194268
[TBL] [Abstract][Full Text] [Related]
44. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
[TBL] [Abstract][Full Text] [Related]
45. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate?
Muragaki Y; Chernov M; Maruyama T; Ochiai T; Taira T; Kubo O; Nakamura R; Iseki H; Hori T; Takakura K
Minim Invasive Neurosurg; 2008 Oct; 51(5):275-9. PubMed ID: 18855292
[TBL] [Abstract][Full Text] [Related]
46. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
[TBL] [Abstract][Full Text] [Related]
47. The role of radiotherapy in the management of spinal cord glioma.
Shirato H; Kamada T; Hida K; Koyanagi I; Iwasaki Y; Miyasaka K; Abe H
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):323-8. PubMed ID: 7673019
[TBL] [Abstract][Full Text] [Related]
48. Improving contrast enhancement in magnetic resonance imaging using 5-aminolevulinic acid-induced protoporphyrin IX for high-grade gliomas.
Yamamoto J; Kakeda S; Yoneda T; Ogura SI; Shimajiri S; Tanaka T; Korogi Y; Nishizawa S
Oncol Lett; 2017 Mar; 13(3):1269-1275. PubMed ID: 28454245
[TBL] [Abstract][Full Text] [Related]
49. Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study.
Nabavi A; Thurm H; Zountsas B; Pietsch T; Lanfermann H; Pichlmeier U; Mehdorn M;
Neurosurgery; 2009 Dec; 65(6):1070-6; discussion 1076-7. PubMed ID: 19934966
[TBL] [Abstract][Full Text] [Related]
50. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
Haider SA; Lim S; Kalkanis SN; Lee IY
J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
[TBL] [Abstract][Full Text] [Related]
51. In vivo fluorescence navigation of gastric and upper gastrointestinal tumors by 5-aminolevulinic acid mediated photodynamic diagnosis with a laser-equipped video image endoscope.
Isomoto H; Nanashima A; Senoo T; Ogiwara K; Hashisako M; Ohnita K; Yamaguchi N; Kunizaki M; Hidaka S; Fukuda H; Ishii H; Matsushima K; Minami H; Akazawa Y; Takeshima F; Fukuoka J; Nagayasu T; Nakao K
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):201-8. PubMed ID: 25840141
[TBL] [Abstract][Full Text] [Related]
52. Predictive value of intraoperative 5-aminolevulinic acid-induced fluorescence for detecting bone invasion in meningioma surgery.
Della Puppa A; Rustemi O; Gioffrè G; Troncon I; Lombardi G; Rolma G; Sergi M; Munari M; Cecchin D; Gardiman MP; Scienza R
J Neurosurg; 2014 Apr; 120(4):840-5. PubMed ID: 24410157
[TBL] [Abstract][Full Text] [Related]
53. [Biopsy and resection of skull base tumors using transorbital endoscopic approaches: primary results].
Golbin DA; Lasunin NV; Cherekaev VA; Grigorieva NN; Serova NK; Mindlin SN; Kutin MA; Imaev AA
Zh Vopr Neirokhir Im N N Burdenko; 2019; 83(3):42-56. PubMed ID: 31339496
[TBL] [Abstract][Full Text] [Related]
54. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
Chohan MO; Berger MS
J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
[TBL] [Abstract][Full Text] [Related]
55. The role of 5-aminolevulinic acid in spinal tumor surgery: a review.
Wainwright JV; Endo T; Cooper JB; Tominaga T; Schmidt MH
J Neurooncol; 2019 Feb; 141(3):575-584. PubMed ID: 30594965
[TBL] [Abstract][Full Text] [Related]
56. 3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.
Caivano R; Lotumolo A; Rabasco P; Zandolino A; D'Antuono F; Villonio A; Lancellotti MI; Macarini L; Cammarota A
Int J Neurosci; 2013 Aug; 123(8):537-43. PubMed ID: 23390934
[TBL] [Abstract][Full Text] [Related]
57. Is it appropriate to redefine the indication for stereotactic brain biopsy in the MRI Era? Correlation with final histological diagnosis in supratentorial gliomas.
Callovini GM
Minim Invasive Neurosurg; 2008 Apr; 51(2):109-13. PubMed ID: 18401825
[TBL] [Abstract][Full Text] [Related]
58. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers.
Hosmann A; Millesi M; Wadiura LI; Kiesel B; Mercea PA; Mischkulnig M; Borkovec M; Furtner J; Roetzer T; Wolfsberger S; Phillips JJ; Berghoff AS; Hervey-Jumper S; Berger MS; Widhalm G
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34064222
[TBL] [Abstract][Full Text] [Related]
59. 5-ALA fluorescence-guided endoscopic surgery for mixed germ cell tumors.
Takeda J; Nonaka M; Li Y; Komori Y; Kamei T; Iwata R; Hashiba T; Yoshimura K; Asai A
J Neurooncol; 2017 Aug; 134(1):119-124. PubMed ID: 28528422
[TBL] [Abstract][Full Text] [Related]
60. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement.
Widhalm G; Wolfsberger S; Minchev G; Woehrer A; Krssak M; Czech T; Prayer D; Asenbaum S; Hainfellner JA; Knosp E
Cancer; 2010 Mar; 116(6):1545-52. PubMed ID: 20108311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
